TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

Daiichi Sankyo’s FLT3 Inhibitor Quizartinib Treats Relapsed/Refractory FLT3-ITD AML

Daiichi Sankyo Company Limited announced quizartinib an investigational FLT3 inhibitor for the treatment of adult patients with relapsedrefractory FLT3ITD Acute Myeloid Leukemia AML Quizartinib is the first FLT3 inhibitor to enhance overall survival as an oral single agent compared to chemotherap..

Portola Pharmaceuticals Introduces Antidote for the Reversal of Factor Xa Inhibitors

Portola Pharmaceuticals develops Andexxa coagulation factor Xa recombinant inactivatedzhzo the first and only antidote indicated for patients treated with rivaroxaban and apixaban when reversal of anticoagulation is needed due to lifethreatening or uncontrolled bleeding Andexxas rapid reversal of..

Amgen and Novartis Pharma Collaborate to Develop Novel Approach for Migraine Prevention

Amgen in collaboration with Novartis Pharma AG has developed Aimovig a novel therapeutic approach to prevent a migraine by blocking the calcitonin generelated peptide receptor CGRPR which is believed to play a critical role in a migraine Aimovig 70 mg is selfadministered once monthly via Amgen39s..

World's First Metal-based Probes for Detection of Dopamine Receptors - Developed by HKBU Researchers

A team of researchers of Hong Kong Baptist University has developed the worlds first metalbased probes for the identification of dopamine receptors in living cells This breakthrough innovation helped the researchers to understand the dopamine receptors in carcinogenesis Dopamine is an organic che..

ChargePoint Technology launches VERIFI®- a Intelligent Monitoring Hub

ChargePoint Technology launches firstofitskind intelligent monitoring platform namely VERIFI which helps in tracking the most critical data of numerous valve installations This will send alerts directly to HS maintenance and compliance teams to reduce unplanned maintenance downtime The VERIFI com..

First-of-its-kind Doptelet will soon be Available to Control Life-threatening Bleeding

Dova Pharmaceuticals announced that US Food and Drug Administration FDA has given green signal to Doptelet avatrombopag prescriptive medicine for the treatment of thrombocytopenia in adult patients affecting with a chronic liver disease Doptelet is used to treat low platelet counts in adults affe..

Roche Launches Hemlibra to Treat Haemophilia A without Factor VIII Inhibitors

Roche launches Hemlibra for the treatment of people suffering from haemophilia A without factor VIII inhibitors Hemlibra is a bispecific medicine which is injected under the patients skin in order to develop required proteins activate the natural coagulation cascade and to restore the blood clott..

Optical Sample Patent Approved for Breakthrough Cell Culture Management Technology

The new breakthrough cell management technology now can be safe guarded with a patent right by all the Cell Culture Laboratories working with sensitive cell types Under this protection all the cell laboratories will be ensured for optimal sample security for gene therapy cell therapy and regenera..

FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis

The US Food and Drug Administration FDA grants Proteostasis Therapeutics39 PTI428 a Breakthrough therapy for the treatment of cystic fibrosis patients with two copies of the F508del genetic mutation who are receiving Orkambi as background therapy PTI428 is an investigational CFTR amplifier in the..

FDA Grants Breakthrough Therapy Designation to Fennec PEDMARK™

The US Food and Drug Administration FDA awarded breakthrough therapy designation to Fennec Pharmaceuticals PEDMARK a unique formulation of sodium thiosulfate for prevention of cisplatinrelated ototoxicity in pediatric patients with standardrisk hepatoblastomaSRHB The Fast Track designation will f..